NBCUniversal Media, LLC

Serena Williams opened up to Access Hollywood’s guest correspondent Emily Orozco about her journey with Ro and taking a GLP-1 weight loss medication. Williams, who is a paid spokesperson for the health care company Ro, described that after the birth of her second daughter she struggled to be at the weight that she desired, despite diet and exercise changes.

Serena Williams has taken the first step that would be required ahead of a comeback to tennis, registering with the sport's drug-testing body, a spokesman for the International Tennis Integrity Agency (ITIA) said Tuesday.

The 23-time Grand Slam champion , one of the greats of the game, has not competed since bidding farewell at the 2022 U.S. Open . At the time, Williams said she didn't want to use the

See Full Page